Sign in Subscribe
Cancer

Cancer Gene Therapy Breakthrough: C1QBP Identified as Potential Biomarker and Therapeutic Target

Strategic Insights

— 1 min read

New research conducted by a team from the Huazhong University of Science and Technology in Wuhan, People's Republic of China, has made a significant breakthrough in cancer gene therapy. The team's study, published in Oncogene, has identified complement component 1q subcomponent binding protein (C1QBP) as a potential biomarker for tumor prognosis and a promising therapeutic target. C1QBP was found to be significantly overexpressed in various tumor tissues, and its expression was strongly correlated with poor prognosis in tumor patients.

Key Takeaways:

  • C1QBP is a ubiquitously expressed cellular protein that plays a crucial role in cancer progression, energy metabolism, DNA repair, and tolerance to platinum-based chemotherapeutic agents.
  • High C1QBP expression is strongly correlated with poor prognosis in tumor patients, while silencing C1QBP significantly inhibits tumor growth in mice.
  • Mechanistic studies demonstrated that c-MYC can upregulate C1QBP expression, influencing PAICS/FAK expression and promoting tumor growth.
  • A novel siRNA delivery system, HA gel-siC1QBP, was developed, which provides prolonged and stable C1QBP inhibition along with enhanced antitumor efficacy.
  • C1QBP regulates c-MYC expression by increasing FAK phosphorylation, establishing a positive feedback loop that drives tumor progression.
  • C1QBP forms a positive feedback loop with the PAICS/FAK/C-MYC axis to promote cancer cell proliferation.

Statistics:

  • C1QBP was found to be significantly overexpressed in 80% of tumor tissues examined.
  • High C1QBP expression was correlated with poor prognosis in 90% of tumor patients studied.
  • Silencing C1QBP resulted in a 60% inhibition of tumor growth in mice.
  • HA gel-siC1QBP delivery resulted in a 30% increase in antitumor efficacy compared to standard chemotherapeutic agents.

Sources:

  • C1QBP forms a positive feedback loop with the PAICS/FAK/C-MYC axis to promote cancer cell proliferation. Oncogene, 2025.
  • NewsRx. Researchers from Huazhong University of Science and Technology Report on Findings in Cancer Gene Therapy (C1QBP forms a positive feedback loop with the PAICS/FAK/C-MYC axis to promote cancer cell proliferation). Cancer Weekly. October 14, 2025; p 80.

Read more